|
| |
GaucherDownload PDF containing detailed information.
Recent Publications on Gaucher: |  |
Polyester-based micelles and nanoparticles for the parenteral delivery of taxanes.
Taxanes are potent antimitotic agents that have demonstrated efficacy in a... | 21st November, 2009
| Canada Research Chair in Drug Delivery, Faculty of Pharmacy, University of
| J Control Release. 2009 Nov 16.
DOI Direct Link |
Psychological aspects of patients with Fabry disease.
The Minnesota Muliphasic Personality Inventory (MMPI-2) is widely used in... | 20th November, 2009
| Pacific Graduate School of Psychology at Palo Alto University, 1791
| J Inherit Metab Dis. 2009 Oct 31.
DOI Direct Link |
Compensatory Rationalizations and the Resolution of Everyday Undeserved Outcomes.
People prefer to perceive the world as just; however, the everyday... | 17th November, 2009
|
| Pers Soc Psychol Bull. 2009 Nov 13.
DOI Direct Link |
Effective desensitization to imiglucerase in a patient with type I Gaucher disease.
We describe a child who had anaphylactic hypersensitivity to imiglucerase... | 17th November, 2009
| Department of Pediatrics, University of Verona, Verona, Italy.
| J Pediatr. 2009 Dec;155(6):940-1.
DOI Direct Link |
Substrate deprivation therapy in juvenile Sandhoff disease.
Substrate deprivation therapy has been successfully applied in a number of... | 10th November, 2009
| Department of Paediatrics, Radboud University Nijmegen Medical Centre,
| J Inherit Metab Dis. 2009 Nov 4.
DOI Direct Link |
→View more research publications. |
Press Releases About Gaucher:
|
 |
| Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease |
24th November, 2009 |
|
DUBLIN, November 24 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that it has submitted a MAA to the
European Medicines Agency
|
| FDA Grants Priority Review for Shire's velaglucerase alfa for Type 1 Gaucher Disease |
4th November, 2009 |
|
CAMBRIDGE, Massachusetts, November 4 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced that the United States Food and
Drug
|
| Shire Continues to Deliver Excellent Growth From Core Products |
30th October, 2009 |
|
DUBLIN, October 30 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty
biopharmaceutical company, announces results for the three months to
September 30, 2009.
Q3 2009
|
| Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates |
29th October, 2009 |
Amicus Therapeutics |
-- Advancement of pharmacological chaperones used in combination with
enzyme replacement therapies (ERT) for the treatment of lysosomal
storage diseases.
"By focusing our
|
| Amicus Therapeutics Announces Preliminary Results of Phase 2 Study with Plicera(TM) for Gaucher Disease |
2nd October, 2009 |
Amicus Therapeutics |
CRANBURY, N.J., Oct. 2 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) today announced preliminary results from its Phase 2 randomized, open-label study to assess the safety, tolerability
|
Companies working in the area of Gaucher from Bioportfolio's Biocorporate database : | |
| Company Name | |
Accredo Health, Incorporated ("Accredo") is a Memphis-based parent organization for a family of companies providing specialized contract pharmacy and related services beneficial to patients with...
www.accredohealth.com/ View full profile
| |
Avigen is a leader in the development of gene therapy products derived from adeno-associated virus ("AAV") for the treatment of inherited diseases. Avigen's proposed gene therapy products are designed...
www.avigen.com/ View full profile
| |
BioPortfolio Ltd. offers e-mail and postal lists for Gaucher scientists - we have details of around 393 individuals working on Gaucher .
This page has been viewed 342 times
Recent Search Terms used to find this page: Shire gaucher advisory | Gaucher life expectancy | avigen gaucher | avigen gaucher | phenotype gaucher D409H-H255Q | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Gaucher across BioPortfolio, or for Gaucher Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
